HAVCR2 and neoplasm: Blocking TIM3 can inhibit tumor growth by enhancing antitumor immunity to diseases such as prostate cancer and hepatocellular carcinoma (HCC; Das, Zhu, & Kuchroo, 2017; Ji et al., 2018; Wu et al., 2017).